Experience

AbbVie Inc. v. Boehringer Ingelheim International GmbH

AbbVie Inc.

Boehringer Ingelheim International GmbH

Represented AbbVie in Biologics Price Competition and Innovation (BPCIA) litigation related to Humira®.

AbbVie Inc. v. Boehringer Ingelheim International GmbH, 1:17-cv-01065, D. Del., Judge Goldberg

Related Professionals

William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email
Rachael_Dippold
Rachael P. Dippold, Ph.D.
Associate
Washington, DC
+1 202 408 4063
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Life Sciences

Biologics

Related Experiences

Sandoz Inc. v. Boehringer Ingelheim International GmbH et al.

Boehringer Ingelheim International GmbH et al.

Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.

Biogen International GmbH

Dr Reddy’s Laboratories (UK) Limited v. Boehringer Ingelheim International GmbH*

Boehringer Ingelheim International GmbH

AbbVie Inc. v. Hospira, Inc. 

AbbVie Inc.

AbbVie Inc. v. Matrix Labs

AbbVie Inc.

AbbVie Inc. v. Roxane Laboratories Inc.

AbbVie Inc.

AbbVie Inc. v. Amgen Inc.

AbbVie Inc.

Honeywell International Inc. v. Wintek Corp.

Wintek Corp.

Biogen Int’l GmbH v. Amneal Pharmaceuticals LLC et al.

Biogen Int’l GmbH

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.